Update shared on 18 Dec 2025
Fair value Decreased 0.68%Analysts have nudged their consolidated price target for Northrop Grumman modestly higher to reflect stable mid single digit organic growth, improving long term cash flow visibility from programs like B 21 and Sentinel, and increased budget support across key defense platforms, while fair value edged slightly lower from approximately $667 to $663 per share as a lower discount rate and marginally stronger profit margin outlook were largely offset by a slightly reduced future P E multiple.
Analyst Commentary
Bullish analysts highlight that Northrop Grumman's outlook remains steady, with guidance pointing to mid single digit organic growth through 2026 and visibility into long duration defense programs that underpin both revenue and margin durability.
Recent target price increases and an upgrade to a Buy rating suggest growing conviction that the market is underappreciating the cash flow inflection expected later in the decade as key programs scale and move into more profitable phases.
Bullish Takeaways
- Multiple firms have raised price targets into the mid to high $600s, and one major bank now sees upside toward $700 per share, reflecting greater confidence in long term free cash flow and earnings growth.
- Analysts view Northrop as a primary beneficiary of the 2026 defense budget proposal, citing significantly higher funding for Sentinel and B 21, alongside incremental support for TACAMO and E 2D, which strengthens the multiyear growth runway.
- Exposure to nuclear deterrence, munitions, missiles, and space is seen as tightly aligned with Department of Defense strategic priorities, which supports premium valuation relative to more cyclically exposed peers.
- Bullish analysts point to a post 2028 cash flow inflection as B 21 turns cash profitable and Sentinel nears full production, arguing this should support multiple resilience even as new competitors emerge.
Bearish Takeaways
- Some cautious analysts maintain neutral or market perform stances, suggesting that much of the near term growth from key programs and budget tailwinds is already embedded in current valuation.
- There is concern that government shutdown dynamics and broader fiscal negotiations could inject uncertainty into Q4 and FY 2026 visibility, limiting near term multiple expansion despite solid fundamentals.
- Defense demand is described as more nuanced than commercial aerospace, with potential timing and execution risks around large programs that could pressure margins if schedules slip or costs rise.
- While strategic positioning is strong, bearish analysts argue that the premium valuation leaves less room for error on execution of major programs and on sustaining mid single digit organic growth beyond current guidance.
What's in the News
- The Pentagon is expected to select the builder of the Navy's next generation F A XX stealth fighter as soon as this week, with Northrop Grumman competing against Boeing for the high profile program (Reuters).
- U S defense officials are pressing major missile manufacturers, including Northrop Grumman, to double or even quadruple production capacity to prepare for potential conflict scenarios with China (Wall Street Journal).
- Defense Secretary Pete Hegseth has called an urgent, in person gathering of top U S military commanders, underscoring an elevated focus on strategic readiness that could reinforce demand for defense contractors such as Northrop Grumman (Washington Post).
Valuation Changes
- Fair Value: edged down slightly from approximately $667.21 to $662.68 per share, reflecting a modest recalibration of long term assumptions.
- Discount Rate: decreased slightly from about 8.20 percent to 7.97 percent, implying a marginally lower perceived risk profile or cost of capital.
- Revenue Growth: remained effectively unchanged, easing only fractionally from roughly 5.43 percent to 5.42 percent, indicating a stable top line outlook.
- Net Profit Margin: improved slightly from about 9.39 percent to 9.40 percent, signaling a marginally more favorable profitability expectation.
- Future P/E: declined modestly from around 25.51x to 25.17x, suggesting a slightly lower anticipated valuation multiple on forward earnings.
Have other thoughts on Northrop Grumman?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
